Blazma brings longitudinal diagnostic data, operational context and approved intelligence
into a governed workflow designed around human clinical oversight.
The engine links each requested service to the clinical question, diagnosis, coding, history, preparation, medical necessity, insurance rules and previous results. It can identify missing information, potential duplication, unsuitable preparation, missing approvals, conflicting rules or urgent conditions and direct the request to the appropriate review path.
Previous result available within policy window.
Ready for scheduling.
Approved models and rules can help authorized professionals review complex diagnostic information more consistently and efficiently.
Analyze longitudinal results and highlight meaningful changes over time.
Highlight abnormal changes, critical cases and approved risk stratification signals.
Bring multi-source evidence and contextual signals into a physician-reviewable view.
Blazma can support treatment pathways by documenting decisions, assigning follow-up tests, monitoring biomarkers, comparing new results with expected response and generating approved alerts or tasks for review.
Capture the reason for diagnostic investigation and relevant context.
Execute and validate diagnostic services with traceable results.
Present approved insights and record the authorized clinical decision.
Coordinate follow-up tests and monitor new evidence against the intended pathway.
Blazma can consolidate diagnostic data from clinical systems, LIS platforms, analyzers, referral partners, patient channels, payers and authorized national systems while preserving provenance and ownership.
Connect authorized diagnostic events over time to support continuity of care, trend review and governed analysis.
Use aggregated, governed evidence to understand disease burden, screening coverage, abnormal-result patterns and follow-up gaps.
Compare population needs with laboratory, workforce, supplies, logistics, referral and outreach capacity.
Every clinical AI use case should have a defined purpose, intended users, approved data sources, expected output, performance thresholds, limitations and accountable clinical owner.
Evaluate clinical relevance, performance, explainability, bias and safety before production.
Apply role-based access and approved-purpose restrictions to data, inputs and outputs.
Track performance, bias, drift, safety, user behavior and clinical impact after deployment.
Retain model versions and outputs and provide a defined deactivation or fallback process.